Back to Search
Start Over
In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells
- Source :
- Research in Pharmaceutical Sciences, Vol 15, Iss 2, Pp 200-208 (2020), Research in Pharmaceutical Sciences
- Publication Year :
- 2020
- Publisher :
- Wolters Kluwer Medknow Publications, 2020.
-
Abstract
- Background and purpose: An anticancer peptide P28, has shown to be cytolethal on various cancer cells including breast cancer. Moreover, p28 can be also used as a targeting moiety in the structure of fusion proteins. IL-24 (or its truncated form, M4) is a cytokine with anticancer activity against a wide range of tumor cells. We aimed at production of a fusion protein consisted of p28 and either IL-24 or M4 to target breast cancer. However, selection of a proper linker to join the two moieties without intervening each other’s function is a key factor in the construction of fusion proteins. In the present study, the impact of different linkers on construction of the two chimeric proteins (p28-IL-24 and p28-M4) was assessed in silico . Experimental approach: After selection of some linkers with different lengths and characteristics, a small library of the chimeric proteins was created and assessed. Furthermore, following selection of the most suitable linker, the three-dimensional structures and dynamic behavior of both fusion proteins were evaluated by homology modeling and molecular dynamic simulation, respectively. Findings / Results: Based on the results, a rigid linker having the peptide sequences of AEAAAKEAAAKA showed highest freedom of action for both moieties. Conclusion and implications: Between the p28-IL-24 and p28-M4 fusion proteins, the former showed better stability as well as solubility and might show stronger anticancer effects in vitro and in vivo , because its peptide moieties showed to exert their activities freely.
- Subjects :
- chemistry.chemical_classification
Chemistry
In silico
p28
Peptide
Homology modeling
Computational biology
Fusion protein
In vitro
RS1-441
Breast cancer
Pharmacy and materia medica
IL-24
Cancer cell
Molecular Dynamic Simulation
fusion protein
il-24
homology modeling
molecular dynamic simulation
breast cancer
Original Article
General Pharmacology, Toxicology and Pharmaceutics
Linker
Function (biology)
Subjects
Details
- Language :
- English
- ISSN :
- 17359414 and 17355362
- Volume :
- 15
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Research in Pharmaceutical Sciences
- Accession number :
- edsair.doi.dedup.....d8b268477cc01e283837892176d7695e